{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:26:57Z","timestamp":1767857217150,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cca.2024.119672","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T13:41:20Z","timestamp":1713188480000},"page":"119672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation"],"prefix":"10.1016","volume":"558","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-5765","authenticated-orcid":false,"given":"Yunfeng","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuainan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2024.119672_b0005","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v5.i2.115","article-title":"Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease","volume":"5","author":"Lopez","year":"2014","journal-title":"World J. Diabetes"},{"issue":"3","key":"10.1016\/j.cca.2024.119672_b0010","article-title":"Negative ion chemical ionization gas chromatography\/mass spectrometry and gas chromatography\/tandem mass spectrometry of prostanoid pentafluorobenzyl ester\/methoxime\/trimethylsilyl ether derivatives","volume":"15","author":"Schweer","year":"1988","journal-title":"Biomed. Environ. Mass Spectrom."},{"issue":"3","key":"10.1016\/j.cca.2024.119672_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/0090-6980(93)90048-C","article-title":"11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs","volume":"45","author":"Yamanaka","year":"1993","journal-title":"Prostaglandins"},{"issue":"11","key":"10.1016\/j.cca.2024.119672_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/j.1530-0277.2008.00773.x","article-title":"Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day","volume":"32","author":"Signore","year":"2008","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.cca.2024.119672_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2014.06.023","article-title":"Evaluation of matrix effects using a spike recovery approach in a dilute-and-inject liquid chromatography-tandem mass spectrometry opioid monitoring assay","volume":"437","author":"Mathias","year":"2014","journal-title":"Clinica Chimica Acta; Int. J. Clin. Chem."},{"issue":"12","key":"10.1016\/j.cca.2024.119672_b0030","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12026","article-title":"Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk","volume":"10","author":"Olson","year":"2012","journal-title":"J. Thrombosis Haemostasis : JTH"},{"issue":"11","key":"10.1016\/j.cca.2024.119672_b0035","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-12-1421","article-title":"Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction","volume":"77","author":"DeFilippis","year":"2013","journal-title":"Circ J"},{"issue":"16","key":"10.1016\/j.cca.2024.119672_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)68855-1","article-title":"Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites","volume":"256","author":"Roberts","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cca.2024.119672_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/0090-6980(93)90117-P","article-title":"Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man","volume":"45","author":"Chiabrando","year":"1993","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cca.2024.119672_b0050","unstructured":"CLSI, C62 Liquid chromatography\u2013mass spectrometry methods, 2014. https:\/\/www.clsi.org\/standards\/products\/clinical-chemistry-and-toxicology\/documents\/c62\/ (Accessed October 2023)."},{"key":"10.1016\/j.cca.2024.119672_b0055","unstructured":"CLSI, EP28 Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory, 3rd Edition, 2010. https:\/\/www.clsi.org\/standards\/products\/method-evaluation\/documents\/ep28\/. (Accessed October 2023)."},{"issue":"1 Pt 1","key":"10.1016\/j.cca.2024.119672_b0060","article-title":"Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles","volume":"32","author":"Sinton","year":"1986","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2024.119672_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2014.01.004","article-title":"Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT study","volume":"40","author":"Benhamou","year":"2014","journal-title":"Diabetes Metab."},{"issue":"3","key":"10.1016\/j.cca.2024.119672_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.05.011","article-title":"Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation","volume":"170","author":"Pastori","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.cca.2024.119672_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2016.10.022","article-title":"Oxidative stress reflected by increased F(2)-isoprostanes is associated with increasing urinary 11-dehydro thromboxane B(2) levels in patients with coronary artery disease","volume":"148","author":"McCullough","year":"2016","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.cca.2024.119672_b0080","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.D023739","article-title":"A simple and robust UPLC-SRM\/MS method to quantify urinary eicosanoids","volume":"53","author":"Sterz","year":"2012","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.cca.2024.119672_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/0003-2697(86)90247-2","article-title":"Long-lived enzymatic metabolites of thromboxane B2 in the human circulation","volume":"155","author":"Lawson","year":"1986","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.cca.2024.119672_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2796.1994.tb01049.x","article-title":"Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain","volume":"235","author":"Foegh","year":"1994","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2024.119672_b0095","article-title":"Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B(2)","volume":"5","author":"van der Plas","year":"2018","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.cca.2024.119672_b0100","doi-asserted-by":"crossref","first-page":"106819.05","DOI":"10.1016\/j.vph.2020.106819","article-title":"Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity","volume":"136","author":"Lee","year":"2021","journal-title":"Vasc.Pharmacol."},{"key":"10.1016\/j.cca.2024.119672_b0105","volume":"11","author":"Piechota","year":"2022","journal-title":"Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome"},{"key":"10.1016\/j.cca.2024.119672_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2022.07.048","article-title":"Analysis of admission thromboelastogram profiles in 1369 male and female trauma patients","volume":"280","author":"Favors","year":"2022","journal-title":"J. Surg. Res."},{"issue":"24","key":"10.1016\/j.cca.2024.119672_b0115","doi-asserted-by":"crossref","DOI":"10.2174\/0929867323666161029223512","article-title":"A focused review of gender differences in antithrombotic therapy","volume":"24","author":"Salzano","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"10.1016\/j.cca.2024.119672_b0120","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2007.101014","article-title":"Aspirin responsiveness in healthy volunteers measured with multiple assay platforms","volume":"54","author":"Karon","year":"2008","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.cca.2024.119672_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","volume":"28","author":"Lordkipanidz\u00e9","year":"2007","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.cca.2024.119672_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/BF01721672","article-title":"Energy deficiency, calcium overload or oxidative stress: possible causes of irreversible ischemic myocardial injury","volume":"67","author":"Piper","year":"1989","journal-title":"Klin. Wochenschr."},{"issue":"1","key":"10.1016\/j.cca.2024.119672_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/BF03256268","article-title":"AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect","volume":"12","author":"Geske","year":"2008","journal-title":"Mol. Diagn. Ther."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124019132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:26:54Z","timestamp":1717201614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124019132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":27,"alternative-id":["S0009898124019132"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119672","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119672"}}